Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Tango Therapeutics Inc (NASDAQ: TNGX) closed at $2.62 in the last session, down -8.39% from day before closing price of $2.86. In other words, the price has decreased by -$8.39 from its previous closing price. On the day, 0.71 million shares were traded. TNGX stock price reached its highest trading level at $2.81 during the session, while it also had its lowest trading level at $2.585.
Ratios:
We take a closer look at TNGX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.00 and its Current Ratio is at 8.00. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 17, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On February 12, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $18.Piper Sandler initiated its Overweight rating on February 12, 2024, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Rothenberg Mace bought 10,000 shares for $3.78 per share. The transaction valued at 37,800 led to the insider holds 31,250 shares of the business.
Rothenberg Mace bought 10,000 shares of TNGX for $36,200 on Nov 14 ’24. The Director now owns 21,250 shares after completing the transaction at $3.62 per share. On Nov 06 ’24, another insider, EcoR1 Capital, LLC, who serves as the 10% Owner of the company, sold 1,494,558 shares for $3.28 each. As a result, the insider received 4,896,023 and left with 11,836,178 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNGX now has a Market Capitalization of 281435136 and an Enterprise Value of 25782684. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.49 while its Price-to-Book (P/B) ratio in mrq is 1.23. Its current Enterprise Value per Revenue stands at 0.594 whereas that against EBITDA is -0.188.
Stock Price History:
The Beta on a monthly basis for TNGX is 0.82, which has changed by -0.75065386 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, TNGX has reached a high of $13.01, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is -24.74%, while the 200-Day Moving Average is calculated to be -63.28%.
Shares Statistics:
According to the various share statistics, TNGX traded on average about 1.97M shares per day over the past 3-months and 901270 shares per day over the past 10 days. A total of 107.41M shares are outstanding, with a floating share count of 49.85M. Insiders hold about 53.59% of the company’s shares, while institutions hold 48.08% stake in the company. Shares short for TNGX as of 1735603200 were 7493267 with a Short Ratio of 3.80, compared to 1732838400 on 7222311. Therefore, it implies a Short% of Shares Outstanding of 7493267 and a Short% of Float of 12.85.
